Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Mehdi Razavi, MD

216.444.6697

Mehdi Razavi, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code J2-3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.444.6740
WorkFax:216.445.6174
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Mehdi Razavi, MD, is a Cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic and a Fellow of the American College of Cardiology and the Society of Cardiac Angiography. Dr. Razavi is a member of the Council on Rheumatic Fever and Congenital Heart Disease for the American Heart Association.

Dr. Razavi has authored and co-authored a number of articles on heart disease in publications such as the Journal of the American College of Cardiology, the American Journal of Cardiology and Circulation. He has also written a chapter called "Myocardial Infarction and Normal Coronary Arteriography" for a book entitled Current Practice of Cardiology.

A graduate of the Isfahan Medical School in Iran, Dr. Razavi did his internship at the Martland Medical Center in New Jersey and residency at Akron City Hospital. He completed his fellowship in cardiovascular disease at the Cleveland Clinic, Cleveland, Ohio.

Education & Fellowships

Fellowship - Cleveland Clinic
Cardiology
Cleveland, OH USA
1967
Residency - Akron City Hospital
Internal Medicine
Akron, OH USA
1963
Residency - Medical College of Pennsylvania Hospital
Cardiology
Philadelphia, PA USA
1961
Internship - UMDNJ-University Hospital
Medical Internship
Newark, NJ USA
1960
Medical School - Isfahan University Faculty of Medicine
Isfahan Iran
1957

Specialty Interests

General cardiology

Memberships

  • American College of Cardiology
  • Society of Cardiac Angiography and Intervention
  • American Heart Association
  • American Medical Association

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/30/2014, Dr. Razavi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English